Events /// Investor News /// Investment Case /// Resources
Bayer is committed to providing sustainable solutions that address humanity’s most fundamental needs for essential healthcare and nutritious food. The Bayer Investor Relations Team is dedicated to creating transparency, fostering dialogue, and delivering value to our stakeholders.
Investor News
Share Price / Index
January 30, 2026
Not intended for U.S. and UK Media
Finerenone recommended for the treatment of patients with heart failure with LVEF ≥40% in the EU
January 16, 2026
Bayer welcomes the U.S. Supreme Court decision to review the Durnell case in the Roundup™ litigation
January 16, 2026
Not intended for U.S. and UK Media
Eylea™ 8 mg approved in the EU for third retinal indication
Discover More
